Cite

    Xi, M. et al. (2022). Design, synthesis, biological evaluation and molecular modeling of N-isobutyl-N-((2-(p-tolyloxymethyl)thiazol-4yl)methyl)benzo[d][1, 3] dioxole-5-carboxamides as selective butyrylcholinesterase inhibitors. Bioorganic & medicinal chemistry letters. p. . [Online].